BlackRock Fund Advisors’s Adverum Biotechnologies ADVM Stock Holding History

BlackRock Fund Advisors’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.2M	Sell	75,871 -43,538	-36%	-$1.42M	﹤0.01%	3152
2016 Q3	$4.91M	Buy	119,409 +8,619	+8%	+$327K	﹤0.01%	2852
2016 Q2	$3.5M	Buy	110,790 +27,263	+33%	+$1.23M	﹤0.01%	3010
2016 Q1	$4.32M	Buy	83,527 +997	+1%	+$55.7K	﹤0.01%	2817
2015 Q4	$7.86M	Sell	82,530 -6,160	-7%	-$541K	﹤0.01%	2585
2015 Q3	$7.31M	Buy	88,690 +4,728	+6%	+$604K	﹤0.01%	2562
2015 Q2	$13.6M	Buy	83,962 +30,760	+58%	+$10.4M	﹤0.01%	2335
2015 Q1	$21.6M	Buy	53,202 +7,691	+17%	+$3.25M	0.01%	2031
2014 Q4	$24.6M	Buy	45,511 +28,516	+168%	+$11M	0.01%	1940
2014 Q3	$5.81M	Buy	+16,995	New	+$5.06M	﹤0.01%	2662

Other funds holding ADVM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock Fund Advisors's ADVM Position: Q4 2016 in Review

BlackRock Fund Advisors reduced its Adverum Biotechnologies (ADVM) stake by 36% in Q4 2016, selling an estimated $1.42M and leaving 75,871 shares worth $2.2M. The position accounts for ﹤0.01% of the portfolio, ranked #3152.

BlackRock Fund Advisors first reported a position in ADVM in Q3 2014 and has held it in 10 quarters since. The position peaked at $24.6M in Q4 2014. 83 funds tracked by Wall St. Rank hold ADVM as of Q4 2016.

BlackRock Fund Advisors held 75,871 shares of Adverum Biotechnologies worth $2.2M as of Q4 2016.
BlackRock Fund Advisors sold 43,538 Adverum Biotechnologies shares in Q4 2016, an estimated $1.42M.
Adverum Biotechnologies made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3152 holding.
BlackRock Fund Advisors first reported a position in Adverum Biotechnologies in Q3 2014 and has held it in 10 quarters since.
BlackRock Fund Advisors's Adverum Biotechnologies position peaked at $24.6M in Q4 2014.
83 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.